Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Biocides; animal or insect repellents or attractants
Patent
1990-05-09
1992-06-16
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Biocides; animal or insect repellents or attractants
424497, 424 43, 514946, 514970, 530307, 930 60, A01N 2502, A01N 2528, A61K 916, A61K 3702
Patent
active
051223767
ABSTRACT:
Compositions comprising a calcitonin gene related peptide and, as an absorption enhancer, a glycyrrhizinate.
REFERENCES:
patent: 3988309 (1976-10-01), Matsuda et al.
patent: 4278657 (1981-07-01), Tezuka
patent: 4294829 (1981-10-01), Suzuki et al.
patent: 4304692 (1981-12-01), Hughes et al.
patent: 4393200 (1983-07-01), Miyashita et al.
patent: 4476116 (1984-10-01), Anik
patent: 4481187 (1984-11-01), Kondo
patent: 4530838 (1985-07-01), Evans et al.
patent: 4548922 (1985-10-01), Carey et al.
patent: 4549986 (1985-10-01), Evans et al.
patent: 4597900 (1986-07-01), Orlowski et al.
patent: 4652441 (1987-03-01), Okada
patent: 4711782 (1987-12-01), Okada
patent: 4835142 (1989-05-01), Suzuki
patent: 4917893 (1990-04-01), Okada
L. Illum, Archiv. for Pharmaci og Chemi, vol. 94, pp. 127-135, 1987.
K. Morimoto et al., J. Pharm. Pharmacol., 37, 134-136, 1985.
Derwent Abstract: 88-045809/07 of Japan 63002932A, published Jan. 7, 1988.
R. Ziegler, G. Holz, W. Steibl & F. Rave, Acta. Endocrinol., Supple (215), 54-55, 1978.
Derwent Abstract 85-320779/51 of Japan 60224616A published Oct. 9, 1985.
Derwent Abstract 85-246152/40 of Japan 60-161924A, published Aug. 23, 1985.
M. Mishima, W. Wakita, M. Nakano, Presentation at International Conference dated Apr. 2, 1987.
M. Mishima, Y. Wakita, M. Nakano, M. Hirota, S, Ikei, M. Akagi-Presentation at Conference Oct. 20-21, 1986.
S. Oakada, M. Mishima, M. Nakano, S. Ikei, M. Akagi, and S. Shibata-Japanese Pharmacological Meeting, Apr. 4, 1988.
M. Mishima et al., J. Pharmacobio-Dyn, 10, s-69 (1987).
S. Hirai, T. Yashiki and Mima, Int. J. Pharmaceutics 9, 165-172 and 173-184, (1981).
S. Hirai et al., Diabetes, vol. 27, No. 3, p. 296, 1978.
Derwent Abstract 82491 D/45 of Japan 56122309, published Sep. 25, 1981.
Derwent Abstract 92092D/50 of Japan 56140924, published Nov. 4, 1981.
K. Morimoto et al., J. Pharm. Pharmacol., vol. 37, p. 759, 1985.
M. R. Gibson, Lloydia, vol. 41, No. 4, pp. 348-349 (1978).
E. Azaz & R. Segal, Pharm. Acta. Helv., 55, Nr. 6, pp. 183-186 (1980).
Chem. Abs. 84: 155579d (1976) of A. Otsuka et al., Yakugaku Zasshi, 96(2), 203-8, (1976).
R. Segal, E. Touitou & S. Pisanty, Fourth Int. Conf. on Pharmaceutical Technology, Jun. 1986, Paris.
R. Segal and S. Pisanty, J. Clinical Pharmacy & Therapeutics 12, 165-171 (1987).
Derwent Abstract: 87-104723/15 of Japan 62051604, published Mar. 6, 1987.
Derwent Abstract: 83-773656 Japan 58140014A published Aug. 19, 1983.
Derwent Abstract 82-66899E Japan 57106612A published Jul. 12, 1982.
Mishima et al., J. Pharmacobio-Dyn, 12, 31-36 (1989).
Aliverti Valerio
Dorigotti Luciano
Fonio Teodoro
Pinza Mario
Azpuru Carlos
Dinner Dara L.
ISF Societa per Azioni
Lentz Edward T.
Page Thurman K.
LandOfFree
Calcitonin gene related peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcitonin gene related peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcitonin gene related peptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1752688